Regeneron’s new cancer-fighting duo just made waves: in a small trial, every untreated patient with aggressive blood cancer (DLBCL) saw their disease disappear after getting this experimental therapy plus chemo. The secret sauce? Odronextamab, a bispecific antibody, teams up your immune system to wipe out cancer cells—no need for the usual rituximab. The higher dose is moving forward in studies, and honestly, this could be a game-changer for blood cancer treatment! #Health #BodyHealth #CancerResearch